James Paul Mobley, NP
Nurse Practitioner · Tillamook
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 7 years
- Graduated 2019
Offices
1 location · Northwest Medical Foundation of Tillamook · 80 clinicians in this group
Hospitals listed: Adventist Health Tillamook. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call James Paul Mobley’s office at (503) 815-2260 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health TillamookTillamook, ORCritical Access Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 4 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Adventist Health Tillamook
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 12.8 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.2 · 36 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 263 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 50 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -23.4 · 51 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 51 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.7 to 8.6) · 59 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.1 to 14.1) · 59 cases | No different | Jan 2024 – Dec 2024 |
What patients said (114 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Medicaid work
$19,828 in 2024
Medicaid paid $19,828 for 257 billed services this clinician did in 2024, up to 50 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 257 | $19,828 |
| 2024 | 257 | 1 | 50 | $19,828 |
| 2023 | 585 | 3 | 30 | $21,708 |
| 2022 | 248 | 3 | 36 | $12,572 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 480 | $15,617 |
| Return visit (30+ min) | 93 | $5,475 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 12 | $616 |
2022
| Short return visit (20+ min) | 157 | $7,620 |
| New patient visit (30+ min) | 66 | $4,240 |
| Short return visit | 25 | $713 |
Drugs they prescribed that Part D paid
$1,332
Pharmacies billed $1,332 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
118 generic and 13 brand-name prescriptions · $1,332 in drug cost · 80 antibiotic prescriptions to 72 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 19 | $181 | $9 |
| Nitrofurantoin Mono-Macro | 17 | $140 | $8 |
| Cephalexin | 11 | $51 | $5 |
| Azithromycin | 11 | $30 | $3 |
Year by year
| 2024 | 131 | 102 | None | 10% | $1,332 |
| 2023 | 207 | 157 | None | None | $5,336 |
| 2022 | 136 | 112 | None | None | $2,575 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Amoxicillin-Clavulanate Potass | 25 | $314 | $13 |
| Nitrofurantoin Mono-Macro | 23 | $243 | $11 |
| Cephalexin | 19 | $155 | $8 |
| Azithromycin | 15 | $110 | $7 |
2022: 3 drugs
| Nitrofurantoin | 20 | $675 | $34 |
| Amoxicillin-Clavulanate Potass | 18 | $213 | $12 |
| Cephalexin | 12 | $124 | $10 |
Money from drug and device companies
$24 in 2024
| 2024 | 1 | 1 | None | $24 |
| 2023 | 1 | 3 | None | $49 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Dalvance | $24 | 1 payment
|
See the published payment
| Abbvie | Meals · 2024-02-22 | Dalvance | $24 |
See earlier years (2023)
2023: $49
| Abbvie | Dalvance | $49 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 68.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1760010912
- Licence
- CA 95014509
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2020-03-31
- NPI last updated
- 2021-03-11
- NPI record certified
- 2021-03-11
This is when the NPI record was last certified, not a medical board exam.